DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Lederman RJ, Mendelsohn FO, Anderson RD. et al.
Therapeutic angiogenesis with recombinant fibroblast growth factor – 2 for intermittent claudication (the TRAFFIC study): a randomised trial.
Lancet 2002;
359: 2053-8.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.